Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03991832
Title Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto


Advanced Solid Tumor

biliary tract cancer

adult astrocytic tumour


Durvalumab + Olaparib

Age Groups: adult | senior
Covered Countries CAN

Additional content available in CKB BOOST